Neuland Laboratories Limited (BOM:524558)
17,068
+309 (1.84%)
At close: May 29, 2026
Neuland Laboratories Revenue
In the fiscal year ending March 31, 2026, Neuland Laboratories had annual revenue of 20.23B INR with 36.98% growth. Neuland Laboratories had revenue of 7.76B in the quarter ending March 31, 2026, with 136.40% growth.
Revenue
20.23B
Revenue Growth
+36.98%
P/S Ratio
10.82
Revenue / Employee
11.28M
Employees
1,794
Market Cap
218.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 20.23B | 5.46B | 36.98% |
| Mar 31, 2025 | 14.77B | -817.43M | -5.24% |
| Mar 31, 2024 | 15.59B | 3.67B | 30.81% |
| Mar 31, 2023 | 11.91B | 2.40B | 25.20% |
| Mar 31, 2022 | 9.52B | 147.07M | 1.57% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 23.19B |
| Shilpa Medicare | 15.49B |
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Aarey Drugs & Pharmaceuticals | 3.91B |
| Sai Parenteral's | 3.81B |
| Anlon Healthcare | 1.72B |
| Gujarat Themis Biosyn | 1.66B |
Neuland Laboratories News
- 20 days ago - Neuland Laboratories announces Rs 34 per share dividend and appoints new director - Business Upturn
- 20 days ago - Neuland Laboratories Transcript: Q4 25/26 - Transcripts
- 20 days ago - Neuland Laboratories Quarterly report: Q4 2026 - Filings
- 20 days ago - Neuland Laboratories Slides: Q4 2026 - Filings
- 20 days ago - Neuland Laboratories announces Rs 34 per share final dividend and capacity expansion - Business Upturn
- 20 days ago - Neuland Laboratories reports Rs 2053.1 crore total income for FY26 - Business Upturn
- 20 days ago - Neuland Laboratories reports Rs 2053.1 crore total income for Q4 FY26 - Business Upturn
- 20 days ago - Neuland Laboratories Q4 Results: Net profit jumps 664% YoY to Rs 212.67 crore, revenue surges 136% - Business Upturn